Connor, Clark & Lunn Investment Management (CC&L)
ACOR

Connor, Clark & Lunn Investment Management (CC&L)’s Acorda Therapeutics ACOR Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,986
Closed -$222K – 1213
2020
Q1 		$222K Sell
1,986
-580
-23% -$114K ﹤0.01% 856
2019
Q4 		$628K Sell
2,566
-167
-6% -$42.1K ﹤0.01% 621
2019
Q3 		$941K Buy
2,733
+287
+12% +$156K 0.01% 556
2019
Q2 		$2.25M Buy
2,446
+334
+16% +$410K 0.01% 412
2019
Q1 		$3.37M Buy
2,112
+301
+17% +$542K 0.02% 333
2018
Q4 		$3.38M Buy
1,811
+792
+78% +$1.72M 0.02% 333
2018
Q3 		$2.4M Buy
1,019
+955
+1,492% +$2.96M 0.01% 409
2018
Q2 		$220K Sell
64
-48
-43% -$147K ﹤0.01% 946
2018
Q1 		$318K Buy
+112
New +$335K ﹤0.01% 612
2017
Q3 		– Sell
-279
Closed -$660K – 943
2017
Q2 		$660K Buy
+279
New +$553K ﹤0.01% 556
2016
Q1 		– Sell
-342
Closed -$1.75M – 917
2015
Q4 		$1.75M Sell
342
-26
-7% -$114K 0.01% 362
2015
Q3 		$1.17M Buy
+368
New +$1.43M 0.01% 372
2015
Q2 		– Sell
-79
Closed -$316K – 678
2015
Q1 		$316K Sell
79
-105
-57% -$481K ﹤0.01% 454
2014
Q4 		$903K Buy
+184
New +$790K 0.01% 315

Other funds holding ACOR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s ACOR Position: Q2 2020 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Acorda Therapeutics (ACOR) in Q2 2020, closing a stake of 1,986 shares — an estimated $222K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in ACOR in Q4 2014 and held it in 14 quarters. The position peaked at $3.38M in Q4 2018. 79 funds tracked by Wall St. Rank hold ACOR as of Q2 2020.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Acorda Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 1,986 Acorda Therapeutics shares in Q2 2020, an estimated $222K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Acorda Therapeutics in Q4 2014 and held it in 14 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Acorda Therapeutics position peaked at $3.38M in Q4 2018.
  • 79 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2020.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2020, filed 13 Aug 2020.